Clinical Trials Directory

Trials / Completed

CompletedNCT01645319

Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma

A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Open-Angle Glaucoma

Status
Completed
Phase
Study type
Observational
Enrollment
2,597 (actual)
Sponsor
Agency for Healthcare Research and Quality (AHRQ) · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objectives of the study are: 1. To compare the proportion of patients who achieve a successful response to treatment (reduction in Intraocular Pressure (IOP) of \>15%) between patients treated with laser surgery (including argon laser trabeculectomy, and selective laser trabeculoplasty) with patients receiving additional medications, at 1-year post-treatment initiation. 2. To compare the proportion of patients who achieve a successful response to treatment (reduction in IOP of \>15%) between patients treated with other procedures (including incisional surgery, drainage device procedures, and other glaucoma procedures) with patients receiving additional medications, at 1-year-post-treatment initiation. The study is a prospective, observational cohort study and will not provide or recommend any treatment. Patients who have failed initial medical therapy with two glaucoma medications will be identified and enrolled at the time of scheduling of a laser surgery procedure or other procedure such as incisional surgery or drainage device, or initiation of an additional course of therapy with medication as determined by their physician. This inception cohort of new initiators of laser surgical treatment, other procedures, or additional medical therapy will be followed for 12 months. All decisions regarding treatment are solely at the discretion of the physician in accordance with their usual practice. Enrollment is expected to begin in February 2011 and continue through 12 months of follow-up after enrollment targets have been reached.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2012-07-20
Last updated
2014-01-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01645319. Inclusion in this directory is not an endorsement.